Evidence map›Paper›PMID 32489656›Full record

ArticleJRSM cardiovascular disease

Post-exertional increase in first-phase ejection fraction in recreational marathon runners.

Luca Faconti, Iain Parsons, Bushra Farukh, Ryan McNally, Lorenzo Nesti, Lingyun Fang, Michael Stacey, Neil Hill, David Woods, Phil Chowienczyk

Abstract read
In one paragraph

Article in JRSM cardiovascular disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Luca FacontiDepartment of Clinical Pharmacology, King's College London, British Heart Foundation Centre, London, UK.
Iain ParsonsDepartment of Clinical Pharmacology, King's College London, British Heart Foundation Centre, London, UK.
Bushra FarukhDepartment of Clinical Pharmacology, King's College London, British Heart Foundation Centre, London, UK.
Ryan McNallyDepartment of Clinical Pharmacology, King's College London, British Heart Foundation Centre, London, UK.ORCID https://orcid.org/0000-0003-2395-183X
Lorenzo NestiDepartment of Clinical Pharmacology, King's College London, British Heart Foundation Centre, London, UK.
Lingyun FangDepartment of Clinical Pharmacology, King's College London, British Heart Foundation Centre, London, UK.
Michael StaceyDepartment of Diabetes & Endocrinology, Imperial College, London, UK.
Neil HillAcademic Department of Military Medicine, Research and Clinical Innovation, Royal Centre for Defence Medicine, Birmingham, UK.
David WoodsAcademic Department of Military Medicine, Research and Clinical Innovation, Royal Centre for Defence Medicine, Birmingham, UK.
Phil ChowienczykDepartment of Clinical Pharmacology, King's College London, British Heart Foundation Centre, London, UK.

Funding

British Heart Foundation TG/17/2/33054
6 · The paper itself

Abstract

objectivesRunning a marathon has been equivocally associated with acute changes in cardiac performance. First-phase ejection fraction is a novel integrated echocardiographic measure of left ventricular contractility and systo-diastolic coupling which has never been studied in the context of physical activity. The aim of this study was to assess first-phase ejection fraction following recreational marathon running along with standard echocardiographic indices of systolic and diastolic function.Design and participants: Runners (n = 25, 17 males), age (mean ± standard deviation) 39 ± 9 years, were assessed before and immediately after a marathon race which was completed in 4 h, 10 min ± 47 min.

main outcome measuresCentral hemodynamics were estimated with applanation tonometry; cardiac performance was assessed using standard M-mode two-dimensional Doppler, tissue-doppler imaging and speckle-tracking echocardiography. First-phase ejection fraction was calculated as the percentage change in left ventricular volume from end-diastole to the time of peak aortic blood flow.

resultsConventional indices of systolic function and cardiac performance were similar pre- and post-race while aortic systolic blood pressure decreased by 9 ± 8 mmHg (

conclusionIn recreational marathon runners, there is a marked increase in first-phase ejection fraction after the race despite no other significant change in cardiac performance or conventional measure of systolic function. More detailed physiological studies are required to elucidate the mechanism of this increase.

Indexed as

aerobic capacitydiastolic functionEjection fractionendurancelong distancesystolic function

Identifiers

PMID32489656
PMCPMC7238440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.